外科学总论课件:cancer_第1页
外科学总论课件:cancer_第2页
外科学总论课件:cancer_第3页
外科学总论课件:cancer_第4页
外科学总论课件:cancer_第5页
已阅读5页,还剩66页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

2023/8/24CANCER

—Principles&PracticeofOncology2023/8/24Neoplasms(Tumor,Mass)

Analteredcellpopulationcharacterizedbyanexcessive,nonusefulproliferationofcellsthathavebecomeunresponsivetonormalcontrolmechanismsandtotheorganizinginfluencesofadjacenttissues.2023/8/24ClassificationofNeoplasmsBenigntumorMalignanttumor(Cancer)CarcinomaSarcomaBorderingtumor2023/8/24EssentialsofModernOncologicScienceEssentialsofMoledularBiology:GenomicsandCancerEssentialsofSignalTransductionEssentialsofImmunology2023/8/24PrinciplesofOncologyMolecularBiologyofCancer:OncogenesIdentificationofOncogenesandTumorSuppressorGenesFunctionofOncogenesandTumorSuppressorGenes2023/8/24TumorRelatedGenesOncogene,proto-oncogene

ras,myc,erb2,src,c-fos,c-junetc.Tumorsuppressgene

RB,p53,APC,WT1etc.

DNAdamageandrepairrelatedgene

hMSH2,hMLH1,PMS1,PMS22023/8/24FunctionofOncogenesandTumorSuppressorGenes

SignalTransduction(ras)ExtracellularGrowthFactors(Sis)ReceptorTyrosineKinases(RET)NuclearProteinsandTranscriptionfactors(jun,BRCA1,2,myc,myb)CellCycle/DNADamageResponse(p53,RB,hMSH,MDM-2)2023/8/24MolecularMarkersinCancerDiagnosisChromosomalrearrangementsDNArearrangementsSmallMutation:K-ras,p53,APCTissue-specifictranscriptsViralgenomes2023/8/242023/8/24高通量分析技术——TissueArray2023/8/242023/8/24检测大肠癌及转移灶的不同组织基因表达研究 正常组织、结肠癌及癌旁组织 肝转移组织及淋巴结转移灶

FAP的不同部位的组织块高通量分析技术——基因芯片(GeneChip)基因芯片技术日益成熟,在生命科学领域的应用更为广泛GenePMMMOligo2023/8/24Telomerase,CellAgingandCancer

TimeTelomereLengthCriticalTelomereLengthNormalCellsStem&TumorCells2023/8/24MoledularBiologyofCancerCytogeneticsTheCellCycleApoptosisAngiogenesisInvasionandMetastasis2023/8/242023/8/242023/8/242023/8/24组织细胞数量=细胞增殖-细胞死亡TissueCellNo.=CellProliferation-CellDeath

癌基因和抗癌基因OncogenesandTumorSuppressorGenes凋亡和抗凋亡基因ApoptosisGeneandAnti-apoptosisGene2023/8/24正常粘膜I

癌转移APCK-rasDCCP53nm23?其它甲基化5q突变.缺失12p突变18q突变?缺失17p突变.缺失IIIIIIVAdenomaMCChMSH2hMLH1hPMS1hPMS2ACFCOX-2SNC6,SNC73SNC19,maspin,osteo2023/8/242023/8/24EtiologyofCancerViruses(DNAandRNAViruses)ChemicalFactorsPhysicalFactorsHormonalFactorsCancerGenetics(Hereditaryfactors)2023/8/24肿瘤发生机制环境、饮食生物性因素遗传易感性酶的多态性基因不稳定MSIIntereactionDNA损伤修复修复DNA突变癌变染色体不稳定作用后出现的分子产物(基因与蛋白)

2023/8/24CancerGeneticsCancerasaGeneticDiseaseMechanismsofCancerPredispositionClinicalCharacteristicsofCancerFamiliesMultisystemGeneticSyndromesWithaHighRiskofCancerNonsyndromicHereditaryCancer2023/8/24EpidemiologyofCancerHumanCarcinogenesis:TheNatureoftheEvidenceCancerEpidemiologybySiteAnOverviewofCancerCauses2023/8/24CancerPrevention:PreventingTobacco-RelatedCancersDietandChemopreventiveAgents:Fat:BreastCancer,ColonCancer,ProstateCancerandotherCancerDietaryFibersRetinoids,Carotenoids,andMicronutrientsNaturallyOccurringDietaryAnticarcinogensDietaryCarcinogensAspirinandOtherNonsteroidalAntiinflammatoryDrugsandtheRiskofCancerDevelopmentPhysicalActivityandBodyWeightRoleofSurgeryinCancerPrevention2023/8/24CancerScreeningWhatisCancerScreening?EvaluationofAscreeningTestBreastCancerScreeningCervicalCancerScreeningSkinCancerScreeningProstateCancerScreeningColorectalCancerScreeningLungCancerScreening2023/8/24PathologyofNeoplasmsCarcinogenesisandTumorigenesisTumorcelldifferentiationGrowthpatternGrowthrate(speed)MetastasisDirectExtensionLymphaticSpreadVascularSpreadSpreadthroughSerousCavities2023/8/24CancerDiagnosis:MolecularPathologyImmunohistochemistryDNAContentDiagnosticMolecularGeneticsTechniquesintheMolecularGeneticDiagnosisofCancerMolecularMarkersinCancerDiagnosisSmallMutationsFutureExpectations2023/8/24ClinicalManifestationsCancer’ssevenwarningsignalsChangeinbowelorbladderhabitsAsorethatdoesnothealUnusualbleedingordischargeThickeningorlumpinbreastorelsewhereIndigestionordifficultyinswallowingObviouschangeinwartormoleNaggingcoughorhoarseness2023/8/24LocalmanifestationsofcancerMassPainUlcerBleedingObstructionMetastaticManifestations2023/8/242023/8/242023/8/242023/8/24SystemicManifestationofcancerNon-specific:AnemiaLowfeverWeightlossInertiaAnorexia-cachexiaandothers2023/8/242023/8/24Diagnosisofcancershouldproceedinonorderlyfashion:Carefulhistory(Detailsofriskfactorsincludingfamilyhistoryandcurrentmedicationshouldbenotedinthepatientsrecords)ThoroughphysicalexaminationLaboratoryexaminationImagingexaminationCancerDiagnosis2023/8/24ClinicalBreast

ExaminationInspectionAsymmetrySkinlesionsSkinchangesNippleandareolaabnormalitiesPalpationtechniqueExaminationoftheNippleExaminationofregionallymphnodes(supraclavicular,infraclavicular,axillary)2023/8/24CancerDiagnosis:Imaging—UltrasonographyUltrasonographyisparticularlysuitableforthefollowingpatientgroups:Liver,gallbladder,spleenandpancreaseRetro-peritonealKidneyandadrenalglandBreastandthyroidUltrasoundobservationsBoundariesandshapeInternalechoesPosteriorshadowing2023/8/24CancerDiagnosis:Imaging—ComputedTomographyLiverandgallbladderPancreasandspleenKidneyandAdrenalGlandSmallBowelandColonEsophagusandStomachLungsandMediastinumMusculoskeletalSystemCentralNervousSystem2023/8/24CancerDiagnosis:Imaging—MagneticResonanceImagingBrain,SpineHeadandNeckBreastLiverAdrenalGlands,KidneyUterus,OvaryProstate,BladderMusculoskeletalSystem2023/8/24CancerDiagnosis:

OtherImagingsFunctionalandMetabolicImaging—PositronEmissionTomography(PET)InterventionalRadiologyRadionuclideImaging2023/8/242023/8/24CancerDiagnosis:EndoscopyUpperGastrointestinalEndoscopyEndoscopicUltrasonographySignoidoscopy,ColonoscopyLaparoscopyEndoscopicRetrogradeCholangiopancreatographySmallIntestinalEndoscopy:EnteroscopyPercutaneoisEndoscopicGastrostomyBronchoscopyMediastinoscopyThoracoscopy2023/8/24SpecializedTechniquesinCancerManagemntLaparoscopyVascularAccessandSpecializedTechniquesofDrugDeliveryIsolationPerfusionIntensity-ModulatedRadiationTherapy2023/8/24FineNeedleAspirationIndicationforFNAWhenphysicalexaminationormammographyofthebreastshowsasuspiciousabnormality,eitheradefinitemassorathickeningnotwithinthenormalrange,FNAisindicated.TodistinguishbetweenacystandacarcinomaFNAbiopsyorFNAcytologyUltrasound-guidedFNA2023/8/24BiopsyIndicationsforbiopsyaregenerallyderivedfromtheresultsofphysicalexaminationormammography.Twotechniquesareusedforobtainingtissuesuitableforhistologicalexamination,coreneedlebiopsy,andopenbiopsy.2023/8/24Core-cuttingneedlebiopsyStereotacticallyguidedneedlebiopsyNon-palpablelesionsOpenbiopsyIncisionalbiopsyExcisionalbiopsy(excision,marking,inking,review)Openbiopsyofnon-palpablelesionsHooked-wirelocalizationSpotlocalizationSkinbiopsy(Paget’sdisease,inflammatorycarcinoma)Biopsyofregionaladenopathy2023/8/24StagingCurrently,StagingofcancerisdeterminedbytheTNMsystemofclassification.T tumorN regionallymphnodesM distantmetastases(Primary,Local,RegionalandDistant)2023/8/24PrinciplesofCancerManagement:Goalsoftherapy–CureorPalliationThegoalsoftherapyvarywiththeextentofthecancer.Ifthecancerislocalizedwithoutevidenceofspread,thegoalistoeradicatethecancerandcurethepatient.Whenthecancerisspreadbeyondlocalcure,thegoalistocontrolthepatient’ssymptomsandtomaintainmaximumactivityforthelongestpossibleperiodoftime.2023/8/24PrinciplesofCancerManagement:SurgicalOncologyHistoricalPerspectiveAnesthesiaforOncologicSurgeryDeterminationofOperativeRiskRolesforSurgeryTheSurgicalOncologist2023/8/24SurgicalTherapyCancersurgeryhasbeenbasedupontheconceptthatcancerbeginsasalocaldiseaseandspreadsinanorderlyfashionfromtheprimarysitetoadjacenttissuesbydirectextensiontotheregionallymphnodesbylymphaticsandthroughthebloodvessels.Thesurgicalprocedurewasdesignedtoremovetheprimaryneoplasmsandtheusualcontiguousroutesofspreadwithaimofremovingeverycancercellfromthebody.2023/8/24SurgicalTherapyOnlyaboutone-thirdofcancerpatientsarecuredbysurgeryalone,sincesurgicaltherapy,withfewexceptions,iscurativeonlyinthosepatientsinwhomthediseaseislocalizedtotheprimarysiteandregionalnodes.Advancesinsurgicaltechniques,anesthesia,andsupportivecare(bloodtransfusion,antibiotics,etc)havepermittedthedevelopmentofmoreradicalandextensiveoperativeprocedures.2023/8/24SurgicalTherapyItisessentialtorealizethatthebest,andoftentheonly,opportunityforcureisatthetimeofthefirstoperation,sotheoperativeprocedureshouldbeplannedcarefully.Preventionofcancercellimplantationduringsurgery—localrecurrence.Preventionofvasculardisseminationatsurgery—blood-bornemetastases.“No-touch”technique,earlyligationofthevascularpedicle,etc.2023/8/24SurgicalTherapy:TypesofCancerOperationsLocalresection(atleastincludingsomenormaltissuessurrounding)RadicallocalresectionRadicalresectionwithenblocexcisionoflymphaticsExtensivesurgicalproceduresSurgeryofrecurrentcancerResectionofmetastasesPalliativesurgery2023/8/242023/8/24PrinciplesofCancerManagement:RadiationTherapyPhysicalConsiderationBiologicConsiderationsTumorradiobiologyClinicalConsiderations2023/8/24RadiotherapyObjectivesofRadiotherapyToday,it’srecognizedthatradiologistsmustoptimizetechniquesanddosesofradiotherapyinordertominimizetheriskoflocalrecurrence,achieveexcellentcosmeticresults,andavoidbothshort-andlong-termcomplications.2023/8/24TreatmentPlanningObtainCTScans

DefineTargetArea

EstablishIrradiationField

Construct3DImage

CreateBlocks

ConfirmDoseDistribution2023/8/24ThetechniqueofradiotherapyPatientmarkingsScheduleDoseBoostdoseExternal-beamradiotherapy(X-raysorelectrons)Interstitialimplantation2023/8/24ChemotherapyHistoryChemotherapyasPartoftheInitialTreatmentofCancerClinicalEndpointsinEvaluatingResponsetoChemotherapyPrinciplesGoverningtheUseofCombinationChemotherapyResponsetoChemotherapyIsAffectedbytheBiologyofTumorGrowthThecellCycle,DrugResistance,andtheP53TumorSuppressorGenePathwayTheconceptofDoseIntensityInVitroDrug-ResponseAssays2023/8/24TypesofChemotherapy

TheroleofchemotherapyAdjuvantchemotherapyNeo-adjuvantchemotherapyPalliativechemotherapyHigh-dosechemotherapy2023/8/24AdjuvantchemotherapyRationalforadjuvanttherapySubclinicalmetastases,therapydirectedattheprimarytumorisnothelpful,Systemictherapyaftersurgery,atatimewhenpatientsareclinicallyfreeofdiseasebutareathighriskofhavingresidualmicrometastases.Twotypesofsystemicapproachesareeffective,chemotherapy(cytotoxicagents)andhormonetherapy.2023/8/24AdjuvantchemotherapyTimingofAdjuvantchemotherapyChoiceofchemotherapySingle-agentchemotherapyCombinationchemotherapyNewcytotoxicagentsDoseDurationoftherapy2023/8/24ToxicityofadjuvantchemotherapyCommon:Myelosuppression AlopeciaNausea PrematureovarianfailureVomiting WeightgainLessCommon:SystemicinfectionsThrombosisNeurologicalproblems2023/8/24PalliativechemotherapyBenefits:Metastaticbreastcancerisverytreatableandisoneofthesolidtumormostresponsivetocytoto

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论